Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Pulmonary veno-occlusive disease is highly prevalent in scleroderma patients undergoing lung transplantation.

Gupta S, Gupta A, Rehman S, Ocak I, Domsic RT, Schneider F, George MP.

ERJ Open Res. 2019 Feb 11;5(1). pii: 00168-2018. doi: 10.1183/23120541.00168-2018. eCollection 2019 Feb.

PMID:
30775371
2.

Clinical Presentation, Management, and Prognosis of Pseudogout in Joint Arthroplasty: A Retrospective Cohort Study.

George MP, Ernste FC, Tande A, Osmon D, Mabry T, Berbari EF.

J Bone Jt Infect. 2019 Jan 1;4(1):20-26. doi: 10.7150/jbji.29983. eCollection 2019.

3.

Diagnostic evaluation and management of culture-negative cardiovascular implantable electronic device infections.

Esquer Garrigos Z, George MP, Farid S, Abu Saleh OM, Vijayvargiya P, Mahmood M, Friedman PA, Steckelberg JM, DeSimone DC, Wilson WR, Baddour LM, Sohail MR.

Pacing Clin Electrophysiol. 2018 May 31. doi: 10.1111/pace.13397. [Epub ahead of print]

PMID:
29855048
4.

Impact of Personality Disorder Cluster on Depression Outcomes Within Collaborative Care Management Model of Care.

George MP, Garrison GM, Merten Z, Heredia D Jr, Gonzales C, Angstman KB.

J Prim Care Community Health. 2018 Jan-Dec;9:2150132718776877. doi: 10.1177/2150132718776877.

5.

Initial Pediatric Renal Tumor Imaging: Moving from Good to Better to Best.

George MP, Lee EY.

J Urol. 2018 May;199(5):1125-1126. doi: 10.1016/j.juro.2018.02.065. Epub 2018 Feb 21. No abstract available.

PMID:
29474805
6.

Characterization of PM2.5 in Delhi: role and impact of secondary aerosol, burning of biomass, and municipal solid waste and crustal matter.

Nagar PK, Singh D, Sharma M, Kumar A, Aneja VP, George MP, Agarwal N, Shukla SP.

Environ Sci Pollut Res Int. 2017 Nov;24(32):25179-25189. doi: 10.1007/s11356-017-0171-3. Epub 2017 Sep 18.

PMID:
28924742
7.

Prostacyclin-analog therapy in sickle cell pulmonary hypertension.

Weir NA, Saiyed R, Alam S, Conrey A, Desai HD, George MP, Keeley JH, Klings ES, Mehari A, Taylor JG 6th, Minniti CP, Kato GJ.

Haematologica. 2017 May;102(5):e163-e165. doi: 10.3324/haematol.2015.131227. Epub 2017 Jan 25. No abstract available.

8.

Variables Associated with Chondral and Meniscal Injuries in Anterior Cruciate Ligament Surgery.

Cain EL Jr, Fleisig GS, Ponce BA, Boohaker HA, George MP, McGwin G Jr, Andrews JR, Lemak LJ, Clancy WG Jr, Dugas JR.

J Knee Surg. 2017 Sep;30(7):659-667. doi: 10.1055/s-0036-1593875. Epub 2016 Nov 28.

PMID:
27894146
9.

Precision Medicine in Toxicology.

Schwarz DA, George MP, Bluth MH.

Clin Lab Med. 2016 Dec;36(4):693-707. doi: 10.1016/j.cll.2016.07.010. Review.

PMID:
27842787
10.

Toxicology in Addiction Medicine.

Schwarz DA, George MP, Bluth MH.

Clin Lab Med. 2016 Dec;36(4):685-692. doi: 10.1016/j.cll.2016.07.009. Review.

PMID:
27842786
11.

Toxicology in Pain Management.

Schwarz DA, George MP, Bluth MH.

Clin Lab Med. 2016 Dec;36(4):673-684. doi: 10.1016/j.cll.2016.07.007. Epub 2016 Oct 15. Review.

PMID:
27842785
12.

Semi-automated Quantification of Lung Density on Chest CT Used as a Predictive Biomarker of Pulmonary Venous Hypertension.

Dean KE, Lin F, Kampaktsis PN, George MP, Giambrone A, Coya AB, Juluru K.

Acad Radiol. 2016 Aug;23(8):935-9. doi: 10.1016/j.acra.2016.03.018. Epub 2016 May 18.

PMID:
27209264
13.

Noninfectious and Nonneoplastic Conditions Associated with Human Immunodeficiency Virus Infection.

George MP, Singh V, Gladwin MT.

Semin Respir Crit Care Med. 2016 Apr;37(2):289-302. doi: 10.1055/s-0036-1572560. Epub 2016 Mar 14. Review.

PMID:
26974305
14.

Lung Transplant in Patients with Scleroderma Compared with Pulmonary Fibrosis. Short- and Long-Term Outcomes.

Crespo MM, Bermudez CA, Dew MA, Johnson BA, George MP, Bhama J, Morrell M, D'Cunha J, Shigemura N, Richards TJ, Pilewski JM.

Ann Am Thorac Soc. 2016 Jun;13(6):784-92. doi: 10.1513/AnnalsATS.201503-177OC.

PMID:
26669584
15.

Thrombophilia and the Risk of Recurrent Venous Thromboembolism.

Rhinehart ZJ, Rivera-Lebron B, George MP.

JAMA. 2015 Nov 10;314(18):1975-6. doi: 10.1001/jama.2015.12598. No abstract available.

PMID:
26547471
16.

Infections in the immunosuppressed host.

George MP, Masur H, Norris KA, Palmer SM, Clancy CJ, McDyer JF.

Ann Am Thorac Soc. 2014 Aug;11 Suppl 4:S211-20. doi: 10.1513/AnnalsATS.201401-038PL. Review.

17.

Time to reconsider transplant criteria for candidacy? Lung transplantation feasibility in HIV-infected patients.

George MP.

Ann Am Thorac Soc. 2014 Jul;11(6):962-3. doi: 10.1513/AnnalsATS.201405-212ED. No abstract available.

PMID:
25032871
18.

First successful lung transplantation for sickle cell disease with severe pulmonary arterial hypertension and pulmonary veno-occlusive disease.

George MP, Novelli EM, Shigemura N, Simon MA, Feingold B, Krishnamurti L, Morrell MR, Gries CG, Haider S, Johnson BA, Crespo MM, Bhama JK, Bermudez C, Yousem SA, Toyoda Y, Champion HC, Pilewski JM, Gladwin MT.

Pulm Circ. 2013 Dec;3(4):952-8. doi: 10.1086/674749.

19.

Cellular, pharmacological, and biophysical evaluation of explanted lungs from a patient with sickle cell disease and severe pulmonary arterial hypertension.

Rogers NM, Yao M, Sembrat J, George MP, Knupp H, Ross M, Sharifi-Sanjani M, Milosevic J, St Croix C, Rajkumar R, Frid MG, Hunter KS, Mazzaro L, Novelli EM, Stenmark KR, Gladwin MT, Ahmad F, Champion HC, Isenberg JS.

Pulm Circ. 2013 Dec;3(4):936-51. doi: 10.1086/674754.

20.

Positive affect increases secondary control among causally uncertain individuals.

Tobin SJ, George MP.

Cogn Emot. 2015;29(3):401-15. doi: 10.1080/02699931.2014.916253. Epub 2014 May 6.

PMID:
24801280
21.

Isolated right ventricular dysfunction in patients with human immunodeficiency virus.

Simon MA, Lacomis CD, George MP, Kessinger C, Weinman R, McMahon D, Gladwin MT, Champion HC, Morris A.

J Card Fail. 2014 Jun;20(6):414-421. doi: 10.1016/j.cardfail.2014.03.009. Epub 2014 Apr 12.

22.

Physiologic changes in a nonhuman primate model of HIV-associated pulmonary arterial hypertension.

George MP, Champion HC, Simon M, Guyach S, Tarantelli R, Kling HM, Brower A, Janssen C, Murphy J, Carney JP, Morris A, Gladwin MT, Norris KA.

Am J Respir Cell Mol Biol. 2013 Mar;48(3):374-81. doi: 10.1165/rcmb.2011-0434OC. Epub 2012 Dec 13.

23.

Clutch identity and predator-induced hatching affect behavior and development in a leaf-breeding treefrog.

Gibbons ME, George MP.

Oecologia. 2013 Apr;171(4):831-43. doi: 10.1007/s00442-012-2443-4. Epub 2012 Sep 26.

PMID:
23011848
24.

Serum (1→3)-β-D-glucan levels in HIV-infected individuals are associated with immunosuppression, inflammation, and cardiopulmonary function.

Morris A, Hillenbrand M, Finkelman M, George MP, Singh V, Kessinger C, Lucht L, Busch M, McMahon D, Weinman R, Steele C, Norris KA, Gingo MR.

J Acquir Immune Defic Syndr. 2012 Dec 1;61(4):462-8. doi: 10.1097/QAI.0b013e318271799b.

25.

Systemic delivery of atropine sulfate by the MicroDose Dry-Powder Inhaler.

Corcoran TE, Venkataramanan R, Hoffman RM, George MP, Petrov A, Richards T, Zhang S, Choi J, Gao YY, Oakum CD, Cook RO, Donahoe M.

J Aerosol Med Pulm Drug Deliv. 2013 Feb;26(1):46-55. doi: 10.1089/jamp.2011.0948. Epub 2012 Jun 12.

26.

Injection drug use as a "second hit" in the pathogenesis of HIV-associated pulmonary hypertension.

George MP, Champion HC, Gladwin MT, Norris KA, Morris A.

Am J Respir Crit Care Med. 2012 Jun 1;185(11):1144-6. doi: 10.1164/rccm.201204-0609ED. No abstract available.

27.

Cardiopulmonary function in individuals with HIV infection in the antiretroviral therapy era.

Morris A, Gingo MR, George MP, Lucht L, Kessinger C, Singh V, Hillenbrand M, Busch M, McMahon D, Norris KA, Champion HC, Gladwin MT, Zhang Y, Steele C, Sciurba FC.

AIDS. 2012 Mar 27;26(6):731-40. doi: 10.1097/QAD.0b013e32835099ae.

28.

Lung transplantation for pulmonary hypertension.

George MP, Champion HC, Pilewski JM.

Pulm Circ. 2011 Apr-Jun;1(2):182-91. doi: 10.4103/2045-8932.83455.

29.

A human-mouse chimeric model of obliterative bronchiolitis after lung transplantation.

Xue J, Zhu X, George MP, Myerburg MM, Stoner MW, Pilewski JW, Duncan SR.

Am J Pathol. 2011 Aug;179(2):745-53. doi: 10.1016/j.ajpath.2011.04.014. Epub 2011 Jun 12.

30.

HIV and chronic obstructive pulmonary disease: is it worse and why?

Morris A, George MP, Crothers K, Huang L, Lucht L, Kessinger C, Kleerup EC; Lung HIV Study.

Proc Am Thorac Soc. 2011 Jun;8(3):320-5. doi: 10.1513/pats.201006-045WR. Review.

31.

Pulmonary vascular lesions are common in SIV- and SHIV-env-infected macaques.

George MP, Brower A, Kling H, Shipley T, Kristoff J, Reinhart TA, Murphey-Corb M, Gladwin MT, Champion HC, Morris A, Norris KA.

AIDS Res Hum Retroviruses. 2011 Feb;27(2):103-11. doi: 10.1089/aid.2009.0297. Epub 2010 Oct 21.

32.

Pulmonary function abnormalities in HIV-infected patients during the current antiretroviral therapy era.

Gingo MR, George MP, Kessinger CJ, Lucht L, Rissler B, Weinman R, Slivka WA, McMahon DK, Wenzel SE, Sciurba FC, Morris A.

Am J Respir Crit Care Med. 2010 Sep 15;182(6):790-6. doi: 10.1164/rccm.200912-1858OC. Epub 2010 Jun 3.

33.

CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis.

Gilani SR, Vuga LJ, Lindell KO, Gibson KF, Xue J, Kaminski N, Valentine VG, Lindsay EK, George MP, Steele C, Duncan SR.

PLoS One. 2010 Jan 29;5(1):e8959. doi: 10.1371/journal.pone.0008959.

34.

Respiratory symptoms and airway obstruction in HIV-infected subjects in the HAART era.

George MP, Kannass M, Huang L, Sciurba FC, Morris A.

PLoS One. 2009 Jul 21;4(7):e6328. doi: 10.1371/journal.pone.0006328.

35.

Peripheral T cell functions correlate with the severity of chronic obstructive pulmonary disease.

Zhu X, Gadgil AS, Givelber R, George MP, Stoner MW, Sciurba FC, Duncan SR.

J Immunol. 2009 Mar 1;182(5):3270-7. doi: 10.4049/jimmunol.0802622.

36.

CD28 down-regulation on CD4 T cells is a marker for graft dysfunction in lung transplant recipients.

Studer SM, George MP, Zhu X, Song Y, Valentine VG, Stoner MW, Sethi J, Steele C, Duncan SR.

Am J Respir Crit Care Med. 2008 Oct 1;178(7):765-73. doi: 10.1164/rccm.200701-013OC. Epub 2008 Jul 10.

37.

Cellular and humoral autoreactivity in idiopathic pulmonary fibrosis.

Feghali-Bostwick CA, Tsai CG, Valentine VG, Kantrow S, Stoner MW, Pilewski JM, Gadgil A, George MP, Gibson KF, Choi AM, Kaminski N, Zhang Y, Duncan SR.

J Immunol. 2007 Aug 15;179(4):2592-9.

38.

Urinary pharmacokinetics of 11-nor-9-carboxy-delta9-tetrahydrocannabinol after controlled oral delta9-tetrahydrocannabinol administration.

Gustafson RA, Kim I, Stout PR, Klette KL, George MP, Moolchan ET, Levine B, Huestis MA.

J Anal Toxicol. 2004 Apr;28(3):160-7.

PMID:
15107145
39.

Urinary cannabinoid detection times after controlled oral administration of delta9-tetrahydrocannabinol to humans.

Gustafson RA, Levine B, Stout PR, Klette KL, George MP, Moolchan ET, Huestis MA.

Clin Chem. 2003 Jul;49(7):1114-24.

40.
41.

A pilot study of the use of MaxEPA in haemodialysis patients.

Rylance PB, George MP, Saynor R, Weston MJ.

Br J Clin Pract Suppl. 1984;31:49-54. No abstract available.

PMID:
6091722
42.

Capital management: funding strategy among multi-hospital systems.

Frank F, George MP.

Hosp Financ Manage. 1981 Sep;35(9):24-6, 28, 30-2. No abstract available.

PMID:
10252347
43.

Supplemental Content

Loading ...
Support Center